U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
First publishedAug 5, 08:43 UTC
Last updatedAug 5, 13:35 UTC · 8m ago
1 outlet
NPR Health1 outletNPR News
2 outlets over time — hover a bar for its window & outletslast updated
Answer
Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.(Image credit: Sam Yeh)
Reported by 2 outlets — NPR News, NPR Health. See all sources ↓
Read the full report at NPR News ↗
Why it matters
2 outlets are covering this world story — one to watch as reporting develops.
In brief
- What's the story?
- Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.(Image credit: Sam Yeh)
- How widely is it covered?
- 2 outlets, average source rating 8.5/10.
- When was it last updated?
- 8m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card2 outlets1CoverageScouting report
U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
Sources2TypeCoverage
Related in the knowledge graph
organizationAndorganizationDrug AdministrationorganizationFDAorganizationFoodorganizationImageorganizationSam YehorganizationU.S
Sources (2)
Avg source rating 8.5/10Processing cluster
A1A2A3B1B2B3